| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AXSM over the last quarter tilts toward selling: insiders offloaded a net 118,682 shares worth roughly $26.9M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
Not all activity pointed one way: 1 insider sold in the same window. Classified under Biotechnology (Health Care sector), AXSM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 58.4K | $12.59M | - | |
| Dir | 30.4K | $6.56M | - | |
| COO | 8.7K | $1.87M | - | |
| CFO | 8.2K | $1.77M | - | |
| Other | 7.2K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2015 | Kaye Randall | Chief Medical Officer | Buy | 1,000 | $9.03 | $9,026.00 | +19.9% |